Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Evolus, Inc. (EOLS) Profit Margins

Over the twelve months to 2026-06-30, Evolus, Inc. (EOLS) had gross margin 66.7%, operating margin -5.9%, net margin -10.8%, free cash flow margin -6.9%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EOLSEvolus, Inc.Follow EOLS — free
Drug Manufacturers - Specialty & Generic · Healthcare
—
Price chart with a free account
Market cap
463.0M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin77.1%67.6%56.3%60.4%68.1%68.5%66.3%66.7%
Operating margin-283.3%-270.7%-44.6%-44.0%-24.4%-12.9%-11.0%-5.9%
Net margin-257.8%-288.3%-47.0%-50.1%-30.5%-18.9%-17.4%-10.8%
FCF margin-280.5%-107.9%-34.5%-59.1%-17.6%-8.6%-17.1%-6.9%

USD millions · SEC XBRL

Evolus, Inc. — questions

What is Evolus, Inc.'s gross margin?
66.7% over the twelve months to 2026-06-30.
What is Evolus, Inc.'s operating margin?
-5.9% over the twelve months to 2026-06-30.
What is Evolus, Inc.'s net profit margin?
-10.8% over the twelve months to 2026-06-30.

Every figure on this page comes from Evolus, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.